Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011954
Filing Date
2018-05-09
Accepted
2018-05-08 18:01:36
Documents
51
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cort-10q_20180331.htm 10-Q 934095
2 EX-31.1 cort-ex311_10.htm EX-31.1 15328
3 EX-31.2 cort-ex312_8.htm EX-31.2 15325
4 EX-32.1 cort-ex321_9.htm EX-32.1 6730
5 EX-32.2 cort-ex322_11.htm EX-32.2 6575
  Complete submission text file 0001564590-18-011954.txt   3594453

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cort-20180331.xml EX-101.INS 743245
7 XBRL TAXONOMY EXTENSION SCHEMA cort-20180331.xsd EX-101.SCH 32741
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20180331_cal.xml EX-101.CAL 44140
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20180331_def.xml EX-101.DEF 50543
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20180331_lab.xml EX-101.LAB 224675
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20180331_pre.xml EX-101.PRE 161307
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 18816086
SIC: 2834 Pharmaceutical Preparations